BETA CROSSLAPS; BETA CTx
Beta-Crosslaps is released into the bloodstream during bone resorption and serves as a specific marker for the degradation of mature type I collagen. It can be used to monitor antiresorptive therapy; treatment response is demonstrated as early as three months in contrast to Bone mineral density which may take two years to produce reliable results.
Overnight fasting is mandatory
Sample by Mon 4 pm; Report Same day